Skip to main content

Merck & Co., Inc. income statement

  • MRK · NYSE
  • Pharmaceuticals
  • S&P 500
$147.76+0.55%Close 13 Nov 2026 · Market value $361.6B

Merck & Co., Inc. reported revenue of $65.0 billion for fiscal year 2025 (the twelve months to 31 Dec 2025), up 1.3% from fiscal 2024. Net income was $18.3 billion and diluted earnings per share $7.28.

From Merck & Co., Inc.'s annual and quarterly reports, each period checked against accounting identities; a figure that does not pass is left blank. Fiscal years follow the company's calendar, the latest ending 31 Dec 2025. TTM is the last four reported quarters added up.

Annual

Merck & Co., Inc. income statement, annual
USDFY 2007FY 2008FY 2009FY 2010FY 2011FY 2012FY 2013FY 2014FY 2015FY 2016FY 2017FY 2018FY 2019FY 2020FY 2021FY 2022FY 2023FY 2024FY 2025TTM
Revenue$24.20B$23.85B$27.43B$45.99B$48.05B$47.27B$44.03B$42.24B$39.50B$39.81B$40.12B$42.29B$39.12B$41.52B$48.70B$59.28B$60.12B$64.17B$65.01B$67.38B
Revenue growth—−1.4%+15.0%+67.7%+4.5%−1.6%−6.8%−4.1%−6.5%+0.8%+0.8%+5.4%−7.5%+6.1%+17.3%+21.7%+1.4%+6.7%+1.3%—
Cost of revenue$6.14B$5.58B$9.02B$18.40B$16.87B$16.45B$16.95B$16.77B$14.93B$14.03B$12.91B$13.51B$12.02B$13.62B$13.63B$17.41B$16.13B$15.19B$16.38B$19.03B
Gross profit$18.06B$18.27B$18.41B$27.59B$31.18B$30.82B$27.08B$25.47B$24.56B$25.78B$27.21B$28.79B$27.11B$27.90B$35.08B$41.87B$43.99B$48.98B$48.63B$48.34B
Gross margin74.6%76.6%67.1%60.0%64.9%65.2%61.5%60.3%62.2%64.8%67.8%68.1%69.3%67.2%72.0%70.6%73.2%76.3%74.8%71.8%
Research and development$4.88B$4.80B$5.84B$11.11B$8.47B$8.17B$7.50B$7.18B$6.70B$10.26B$10.34B$9.75B$9.72B$13.40B$12.24B$13.55B$30.53B$17.94B$15.79B$30.76B
Selling, general and administrative$7.56B$7.38B$8.54B$13.13B$13.73B$12.78B$11.91B$11.61B$10.31B$10.02B$10.07B$10.10B$9.46B$8.96B$9.63B$10.04B$10.50B$10.82B$10.73B$11.39B
Operating expenses—————————$20.43B——$19.04B———$40.95B—$26.20B—
Operating income—$10.18B$15.75B$2.37B$8.03B$9.45B$6.35B$18.02B$6.07B$5.35B$7.28B$9.47B$8.06B$6.69B$14.69B$17.41B$3.04B$21.21B$22.42B$6.72B
Operating margin—42.7%57.4%5.1%16.7%20.0%14.4%42.7%15.4%13.4%18.1%22.4%20.6%16.1%30.2%29.4%5.0%33.0%34.5%10.0%
Interest expense—$251.0M$460.0M$715.0M$695.0M$714.0M$801.0M$732.0M$672.0M$693.0M$754.0M$772.0M$893.0M$831.0M$806.0M$962.0M$1.15B$1.27B$1.36B$1.96B
Income before tax$3.49B$9.93B$15.29B$1.65B$7.33B$8.74B$5.54B$17.28B$5.40B$4.66B$6.52B$8.70B$7.17B$5.86B$13.88B$16.44B$1.89B$19.94B$21.07B$4.76B
Income tax expense$95.30M$2.00B$2.27B$671.0M$942.0M$2.44B$1.03B$5.35B$942.0M$718.0M$4.10B$2.51B$1.56B$1.34B$1.52B$1.92B$1.51B$2.80B$2.80B$2.31B
Effective tax rate2.7%20.1%14.8%40.6%12.8%27.9%18.5%30.9%17.4%15.4%62.9%28.8%21.8%22.9%11.0%11.7%80.0%14.1%13.3%48.6%
Net income$3.28B$7.81B$12.90B$861.0M$6.27B$6.17B$4.40B$11.92B$4.44B$3.92B$2.39B$6.22B$9.84B$7.07B$13.05B$14.52B$365.0M$17.12B$18.25B$2.45B
Net margin13.5%32.7%47.0%1.9%13.1%13.0%10.0%28.2%11.2%9.8%6.0%14.7%25.2%17.0%26.8%24.5%0.6%26.7%28.1%3.6%
Net income to common shareholders$3.28B$7.79B$12.85B—$6.26B$6.17B$4.40B$11.92B————$9.84B$7.07B$13.05B$14.52B$365.0M$17.12B$18.25B$2.45B
EPS · diluted$1.49$3.63$5.65$0.28$2.02$2.00$1.47$4.07$1.56$1.41$0.87$2.32$3.81$2.78$5.14$5.71$0.14$6.74$7.28$0.99
Diluted weighted average shares2.2B2.1B2.3B3.1B3.1B3.1B3.0B2.9B2.8B2.8B2.7B2.7B2.6B2.5B2.5B2.5B2.5B2.5B2.5B2.5B
Basic weighted average shares—2.1B2.3B3.1B3.1B3.0B3.0B2.9B2.8B2.8B2.7B2.7B2.6B2.5B2.5B2.5B2.5B2.5B2.5B2.5B
EBITDA—$11.81B$18.33B$9.75B$15.46B$16.43B$13.33B$24.71B$12.45B$10.82B$11.95B$13.99B$11.72B$10.16B$17.92B$21.29B$6.86B$25.71B$28.27B—
EBITDA margin—49.5%66.8%21.2%32.2%34.8%30.3%58.5%31.5%27.2%29.8%33.1%29.9%24.5%36.8%35.9%11.4%40.1%43.5%—
Depreciation & amortization$1.99B$1.63B$2.58B$7.38B$7.43B$6.98B$6.99B$6.69B$6.38B$5.47B$4.68B$4.52B$3.65B$3.47B$3.24B$3.88B$3.83B$4.50B$5.84B—
Stock-based compensation$330.2M$348.0M$415.0M$509.0M$369.0M$335.0M$276.0M$278.0M$299.0M$300.0M$312.0M$348.0M$388.0M$441.0M$479.0M$541.0M$645.0M$761.0M$820.0M$1.06B
Dividends per share$1.52$1.52$1.52$1.52$1.56$1.69$1.73$1.77$1.81$1.85$1.89$1.99$2.26$2.48$2.64$2.80$2.96$3.12$3.28$3.40

Quarterly

Merck & Co., Inc. income statement, quarterly
USDQ4 FY2023Q1 FY2024Q2 FY2024Q3 FY2024Q4 FY2024Q1 FY2025Q2 FY2025Q3 FY2025Q4 FY2025Q1 FY2026Q2 FY2026Q3 FY2026
Revenue$14.63B$15.78B$16.11B$16.66B$15.62B$15.53B$15.81B$17.28B$16.40B$16.29B$16.61B$18.09B
Cost of revenue$3.91B$3.54B$3.75B$4.08B$3.83B$3.42B$3.56B$3.85B$5.55B$4.20B$4.39B$4.89B
Gross profit$10.72B$12.23B$12.37B$12.58B$11.80B$12.11B$12.25B$13.42B$10.85B$12.09B$12.21B$13.19B
Gross margin73.3%77.6%76.8%75.5%75.5%78.0%77.5%77.7%66.2%74.2%73.5%72.9%
Research and development—$3.99B$3.50B$5.86B$4.58B$3.62B$4.05B$4.23B$3.89B$12.59B$9.74B$4.54B
Selling, general and administrative$2.80B$2.48B$2.74B$2.73B$2.86B$2.55B$2.65B$2.63B$2.90B$2.70B$2.90B$2.89B
Operating expenses$12.45B————————$15.15B——
Operating income−$1.74B$5.97B$6.32B$4.42B$4.50B$6.22B$5.30B$7.07B$3.83B−$3.06B−$158.0M$6.11B
Operating margin−11.9%37.9%39.2%26.5%28.8%40.0%33.6%40.9%23.4%−18.8%−1.0%33.8%
Interest expense$310.0M$303.0M$310.0M$330.0M$328.0M$313.0M$305.0M$327.0M$411.0M$479.0M$525.0M$546.0M
Income before tax−$2.05B$5.67B$6.01B$4.09B$4.17B$5.90B$5.00B$6.75B$3.42B−$3.53B−$683.0M$5.56B
Income tax expense−$820.0M$903.0M$545.0M$929.0M$426.0M$818.0M$571.0M$958.0M$458.0M$709.0M$654.0M$492.0M
Effective tax rate40.1%15.9%9.1%22.7%10.2%13.9%11.4%14.2%13.4%−20.1%−95.8%8.9%
Net income−$1.23B$4.76B$5.46B$3.16B$3.74B$5.08B$4.43B$5.79B$2.96B−$4.24B−$1.33B$5.07B
Net margin−8.4%30.2%33.9%19.0%24.0%32.7%28.0%33.5%18.1%−26.0%−8.0%28.0%
Net income to common shareholders−$1.23B$4.76B$5.46B$3.16B$3.74B$5.08B$4.43B$5.79B$2.96B−$4.24B−$1.33B$5.07B
EPS · diluted−$0.48$1.87$2.14$1.24$1.48$2.01$1.76$2.32$1.19−$1.72−$0.54$2.04
Diluted weighted average shares2.5B2.5B2.5B2.5B2.5B2.5B2.5B2.5B2.5B2.5B2.5B2.5B
Basic weighted average shares2.5B2.5B2.5B2.5B2.5B2.5B2.5B2.5B2.5B2.5B2.5B2.5B
EBITDA—————————−$2.03B$912.0M$7.25B
EBITDA margin—————————−12.5%5.5%40.1%
Depreciation & amortization—————————$1.02B$1.07B$1.14B
Stock-based compensation$167.0M$176.0M$203.0M$195.0M$187.0M$195.0M$216.0M$204.0M$205.0M$185.0M$298.0M$369.0M
Dividends per share$0.77$0.77$0.77$0.77$0.81$0.81$0.81$0.81$0.85$0.85$0.85$0.85

The main figures as JSON and plain text. See data and methodology.

MRK in the terminal

Every line back twenty years, charts of any figure, segments and KPIs by quarter, valuation and alerts.